Veru (STU:FMW) Accounts Payable & Accrued Expense : €4.50 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Veru Accounts Payable & Accrued Expense?

Veru's quarterly accounts payable & accrued expense declined from Sep. 2023 (€13.98 Mil) to Dec. 2023 (€11.56 Mil) and declined from Dec. 2023 (€11.56 Mil) to Mar. 2024 (€4.50 Mil).

Veru's annual accounts payable & accrued expense increased from Sep. 2021 (€5.99 Mil) to Sep. 2022 (€30.91 Mil) but then declined from Sep. 2022 (€30.91 Mil) to Sep. 2023 (€13.98 Mil).

Veru Accounts Payable & Accrued Expense Historical Data

The historical data trend for Veru's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Accounts Payable & Accrued Expense Chart

Veru Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.39

4.18

5.99

30.91

13.98

Veru Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															31.60	20.33	13.98	11.56	4.50

Veru Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Veru (STU:FMW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

VERU:USA FMW:Germany

Address

2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website

https://www.verupharma.com

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru (STU:FMW) Headlines

No Headlines